M
Muin J. Khoury
Researcher at Centers for Disease Control and Prevention
Publications - 523
Citations - 40286
Muin J. Khoury is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & Public health. The author has an hindex of 105, co-authored 512 publications receiving 37434 citations. Previous affiliations of Muin J. Khoury include United States Department of Health and Human Services & Université de Montréal.
Papers
More filters
Journal ArticleDOI
From genomic medicine to precision medicine: highlights of 2015.
Charles Auffray,Timothy Caulfield,Julian L. Griffin,Julian L. Griffin,Muin J. Khoury,James R. Lupski,James R. Lupski,Matthias Schwab,Matthias Schwab +8 more
TL;DR: The Section Editors were asked to discuss the breakthroughs in their fields of expertise, and what these might mean for the future of genomic medicine in 2015.
Journal ArticleDOI
Bias Associated with Study Protocols in Epidemiologic Studies of Disease Familial Aggregation
TL;DR: In conclusion, when relatives are identified through cases or controls, they should be included and counted in the study cohorts each time a case or control is selected, even if they or other family members have already been included.
Journal ArticleDOI
Comparative epidemiology of selected midline congenital abnormalities
Ping Yang,Ping Yang,Muin J. Khoury,Muin J. Khoury,Walter F. Stewart,Terri H. Beaty,Elsbeth Chee,Jennifer C. Beatty,Earl L. Diamond,Leon Gordis +9 more
TL;DR: It is concluded from this study that the descriptive epidemiology of diaphragmatic hernia is different from that of the other four defects, which may imply differences in etiologic and pathogenetic mechanisms underlying DH.
Journal ArticleDOI
Monitoring for Congenital Malformations
Neil A. Holtzman,Muin J. Khoury +1 more
TL;DR: Since some teratogens may only cause CMs in newborns, the current approach to monitoring should not be abandoned, since the problems of ascertainment encountered in monitoring newborns are greater still in monitoring abortuses.
Journal ArticleDOI
Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research
Julie Lynch,Julie Lynch,Muin J. Khoury,Ann M. Borzecki,Jerry Cromwell,Laura L. Hayman,Patricia Reid Ponte,Glenn A. Miller,Glenn A. Miller,Christopher S. Lathan +9 more
TL;DR: In 2010, only 12% of US acute-care hospitals ordered the epidermal growth factor receptor assay, suggesting that most patients with lung cancer did not have access to this test.